Mexico Health Review 2019

Page 89

TIMELINE FOR THE INTRODUCTION OF A GENERIC MEDICINE TO THE MARKET

First “generic” sanitary registration

16 months

Patent expires

First market launch of the generic medication

10 months

-10

-20 -25 -30

12 months

• Generics

-28.6%

-15

-23.2%

Market penetration

85

-5

-20.6%

Price variation*

21.4%

1.3%

0

12.7%

6 months

2.5%

5

8.3%

0.4%

GENERICS AFTER PATENT EXPIRATION

• Patents

95 percent of medicines manufactured in Mexico are generics

24 months

*The baseline price is the cost of the patent medication one month after its release

COST DIFFERENCE BETWEEN PATENT AND GENERIC DRUGS IN MEXICO (percentage)

MAIN PHARMACEUTICAL EXPORT DESTINATIONS

51 Others

47

Infectious

Neurological

73

70 Pulmonary

39 Oncologic

0

55 Endocrinology

20

64 Cardiovascular disease

40

Diabetes

60

72

80

MEXICO’S PHARMACEUTICAL EXPORTS

73%

Retail medicines

10%

Wadding, gauze and bandage

9%

Antivenom and vaccines

6%

Pharmaceutical product and preparations

2%

Others

100

80

60

40

46.3% Other 6.7% Colombia 10.3% Panama

20

36.7% US 0

Mexico has 795 pharmaceutical businesses


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.